TM vs ZYME · P/E 9.7, rev $234.60B vs rev $76.3M
Toyota Motor Corporation ADR (TM) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
TM currently screens at market cap $211.00B and trailing P/E 9.7. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the TM and ZYME stock pages for the full models.
Not investment advice.